Editorial e1 Lymphoma in the BiTE era The Lancet Haematology +++ +...

Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00298-4/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-8MLHljUXxFY0oUHnMKaM0b_5WN8K9hNQYn6WSrM11_rmBL608X9KLRDzAyZ-zZ4VhSBdmPfmTVd0cvHIluIA67vcov5A&_hsmi=397926316&utm_content=397442965&utm_source=hs_email Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00315-1/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-8T3BgXM-J2hIpVTLC-r5j_V4uXYtGwz-cd4MJtB6upxkOkwxRO8RCxAcCInO47tYV-WgMzctBlKcWKsjVmygru5-vDRg&_hsmi=397926316&utm_content=397442965&utm_source=hs_email Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00320-5/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-9hM9vQgZSpLvCU4sucObj8LALgApydrYkDnn0yNMsrDBVZXEvCMrQ_czH_-Ufamk8In-GGesQnAm2aM45T4Mh2T30w1w&_hsmi=397926316&utm_content=397442965&utm_source=hs_email Jan 2026 Volume 13Number 1e1-e54 https://www.thelancet.com/journals/lanhae/issue/vol13no1/PIIS2352-3026(25)X0013-2